Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.579,24
0,06%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Incannex Healthcare Ltd (IXHL) Incannex Healthcare Ltd (IXHL) Notizie

Incannex Healthcare Ltd

IXHL
1,8601
0,0601 (3,34%)
27 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/12/202422:04EDGAR2Form 8-K - Current report
09/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06/12/202422:23EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
26/11/202422:06EDGAR2Form S-1/A - General form for registration of securities..
14/11/202422:05GLOBEIncannex Healthcare Inc. Reports Fiscal First Quarter 2025..
12/11/202412:04EDGAR2Form DEF 14A - Other definitive proxy statements
06/11/202422:19EDGAR2Form S-3 - Registration statement under Securities Act of..
06/11/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
31/10/202421:10EDGAR2Form PRE 14A - Other preliminary proxy statements
24/10/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202413:30EDGAR2Form 8-K - Current report
24/10/202413:30GLOBEIncannex Announces Appointment of Dr. Lou Barbato as Chief..
24/10/202413:01EDGAR2Form 8-K - Current report
21/10/202422:35EDGAR2Form 8-K - Current report
15/10/202421:54EDGAR2Form 8-K - Current report
30/9/202422:01EDGAR2Form 8-K - Current report
30/9/202422:01GLOBEIncannex Healthcare Inc. Reports Fiscal Full Year 2024..
30/9/202413:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
10/9/202414:00EDGAR2Form 8-K - Current report
10/9/202414:00GLOBEIncannex Healthcare Announces Strategic Financing for up to..
10/9/202413:30EDGAR2Form 8-K - Current report
10/9/202413:00EDGAR2Form RW - Registration Withdrawal Request
05/8/202413:30GLOBEFDA Review of PsiGAD2 IND complete; clinical trial for..
30/7/202415:00EDGAR2Form 8-K - Current report
30/7/202413:30GLOBEDosing completed in 115 participant..
30/5/202414:30EDGAR2Form 8-K - Current report
30/5/202413:30GLOBEPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial..
07/5/202413:30GLOBEIncannex Complete Successful Pre-IND Meeting with the FDA..
16/4/202414:00GLOBEIncannex Healthcare Inc. Quarterly Update, Q1 2024
28/2/202413:30GLOBEIncannex Announces Positive Topline Results from Phase 2..
16/2/202414:00EDGAR2Form 8-K - Current report
16/2/202413:30GLOBEIncannex Completes Successful Pre-IND Meeting with the FDA..
14/2/202412:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202413:30EDGAR2Form 8-K - Current report
01/2/202413:30GLOBEClarion Clinics Open for Psychedelic-Assisted Treatments
24/1/202422:30EDGAR2Form 8-K - Current report
24/1/202422:05GLOBEIncannex Commences Dosing in Phase 2 Clinical Trial..
18/1/202415:08EDGAR2Form 8-K - Current report
18/1/202414:22GLOBEIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD”..
17/1/202413:30GLOBEIncannex Receives IRB Approval for the RePOSA Phase 2/3..
17/1/202412:05EDGAR2Form 8-K - Current report
Apertura: 1,81 Min: 1,80 Max: 2,03
Chiusura: 1,80

La tua Cronologia

NASDAQ
IXHL
Incannex Healthcare
BIT
BTECH
Fineco Bioprod Tech Tool...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network